Title

New Drugs in Select Gastrointestinal Disorders

Document Type

Conference Presentation

Organization

University of the Pacific

Location

virtual

Conference Dates

April 17-18 & April 24-25, 2021

Date of Presentation

4-17-2021

Abstract

Discuss broadly the clinical presentation and diagnostic criteria related to irritable bowel disease (IBS) and inflammatory bowel disease (IBD). Identify the new drugs which have been approved for IBS and IBD. Discuss the mechanism of action, adverse drug reactions, and monitoring parameters associated with each new drug. Discuss the clinical role and place in therapy of new drugs approved for IBS and IBD.

This document is currently not available here.

Share

COinS